CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

globenewswire

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months – NEWSnet – News… as it used to be

More Press Releases

May 14, 2026

T. Jones Group Named Finalist Across Multiple Categories at the 2026 Georgie Awards

May 14, 2026

/C O R R E C T I O N — Ole Smoky Distillery/

May 14, 2026

Geographic Solutions Expands Customer Success and Growth Leadership Role to Support Evolving State Needs

May 14, 2026

Internationally Acclaimed Landscape Architect Mario Schjetnan to Deliver 2026 Commencement Keynote Speech and Receive Honorary Doctorate from The Boston Architectural College